Key challenges remain, particularly digestive instability, uncertain systemic bioavailability, bitterness, safety standardization, and limited human clinical evidence, so future work should prioritize standardized extraction and analytical methods, optimized delivery systems, and robust clinical trials.
G. Kowalska, Gabriela Rzepkowska, Karolina Miśkiewicz et al.· Molecules· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.